AIDS
- WANG L, Moqueet N, Simkin A, Knight J, et al
Mathematical modelling of the influence of serosorting on the population-level
HIV transmission impact of pre-exposure prophylaxis.
AIDS. 2021 Jan 29. pii: 00002030-900000000-96503.
- MADEDDU G, De Vito A, Cozzi-Lepri A, Cingolani A, et al
Time spent with viral load=200 copies/mL in a cohort of people with HIV seen
for care in Italy during the U=U prevention campaign era.
AIDS. 2021 Jan 29. pii: 00002030-900000000-96502.
- OLIVEIRA NL, Kennedy EH, Tibshirani R, Levine A, et al
Longitudinal 5-year prediction of cognitive impairment among men with HIV
disease.
AIDS. 2021 Jan 29. pii: 00002030-900000000-96501.
- MUCCINI C, Galli L, Poli A, Godino C, et al
Exercise ECG for coronary artery disease screening in people living with HIV: The
cordis STUDY.
AIDS. 2021 Jan 29. pii: 00002030-900000000-96500.
- GEBREBRHAN H, Kambaran C, Sivro A, Adhiambo W, et al
Rectal microbiota diversity in Kenyan men who have sex with men (MSM) is
inversely associated with frequency of receptive anal sex, independent of HIV
status.
AIDS. 2021 Jan 29. pii: 00002030-900000000-96499.
- CHAN P, Kerr SJ, Kroon E, Colby D, et al
Cognitive trajectories after treatment in acute HIV infection.
AIDS. 2021 Jan 29. pii: 00002030-900000000-96498.
Am J Epidemiol
- VANOBBERGHEN F, Weisser M, Kasuga B, Katende A, et al
Mortality Rate in a Cohort of People Living With HIV in Rural Tanzania After
Accounting for Unseen Deaths Among Those Lost to Follow-up.
Am J Epidemiol. 2021;190:251-264.
- MCMANUS H, Callander D, Asselin J, McMahon J, et al
A New Method for Estimating the Incidence of Infectious Diseases.
Am J Epidemiol. 2021 Feb 4. pii: 6127136. doi: 10.1093.
Antimicrob Agents Chemother
- MANDAL S, Prathipati PK, Sunagawa SW, Destache CJ, et al
A new combination bictegravir+tenofovir alafenamide nanoformulation with
prolonged sustained-drug-release potency for HIV-1 PrEP: A concept evaluation
study.
Antimicrob Agents Chemother. 2021 Feb 1. pii: AAC.02320.
Clin Infect Dis
- PEEL J, Chow EPF, Denham I, Schmidt T, et al
Clinical presentation of incident syphilis among men who have sex with men taking
HIV Pre-Exposure Prophylaxis in Melbourne, Australia.
Clin Infect Dis. 2021 Feb 1. pii: 6125283. doi: 10.1093.
- SIEGLER AJ
Needed: A Life Course Perspective on Maintaining Pre-exposure Prophylaxis Use.
Clin Infect Dis. 2021;72:386-387.
- HUANG YA, Tao G, Smith DK, Hoover KW, et al
Persistence With Human Immunodeficiency Virus Pre-exposure Prophylaxis in the
United States, 2012-2017.
Clin Infect Dis. 2021;72:379-385.
- RAUGI DN, Ba S, Cisse O, Diallo K, et al
Long-term Experience and Outcomes of Programmatic Antiretroviral Therapy for
Human Immunodeficiency Virus Type 2 Infection in Senegal, West Africa.
Clin Infect Dis. 2021;72:369-378.
- PAPASAVVAS E, Azzoni L, Ross BN, Fair M, et al
Intact Human Immunodeficiency Virus (HIV) Reservoir Estimated by the Intact
Proviral DNA Assay Correlates With Levels of Total and Integrated DNA in the
Blood During Suppressive Antiretroviral Therapy.
Clin Infect Dis. 2021;72:495-498.
- STALTER RM, Baeten JM, Donnell D, Spinelli MA, et al
Urine Tenofovir Levels Measured Using a Novel Immunoassay Predict Human
Immunodeficiency Virus Protection.
Clin Infect Dis. 2021;72:486-489.
- RUFFIEUX Y, Muchengeti M, Egger M, Efthimiou O, et al
Immunodeficiency and Cancer in 3.5 Million People Living with Human
Immunodeficiency Virus: the South African HIV Cancer Match Study.
Clin Infect Dis. 2021 Feb 2. pii: 6126767. doi: 10.1093.
- PEPPERRELL T, Venter WDF, McCann K, Bosch B, et al
Participants on dolutegravir re-suppress HIV RNA after virologic failure: updated
data from the ADVANCE trial.
Clin Infect Dis. 2021 Feb 2. pii: 6126766. doi: 10.1093.
- WOLTER N, Cohen C, Tempia S, Walaza S, et al
Epidemiology of pertussis in individuals of all ages hospitalised with
respiratory illness in South Africa, January 2013 - December 2018.
Clin Infect Dis. 2021 Feb 2. pii: 6126768. doi: 10.1093.
- DU PREEZ K, Osman M, Seddon JA, Naidoo P, et al
The impact of the evolving HIV response on the epidemiology of tuberculosis in
South African children and adolescents.
Clin Infect Dis. 2021 Feb 3. pii: 6127007. doi: 10.1093.
HIV Med
- PUNEKAR YS, Parks D, Joshi M, Kaur S, et al
Effectiveness and safety of dolutegravir two-drug regimens in virologically
suppressed people living with HIV: a systematic literature review and
meta-analysis of real-world evidence.
HIV Med. 2021 Feb 2. doi: 10.1111/hiv.13050.
- CROXFORD S, Burns F, Copas A, Yin Z, et al
Trends and predictors of linkage to HIV outpatient care following diagnosis in
the era of expanded testing in England, Wales and Northern Ireland: Results of a
national cohort study.
HIV Med. 2021 Feb 2. doi: 10.1111/hiv.13078.
- YANAVICH C, Pacheco AG, Cardoso SW, Nunes EP, et al
Diagnostic value of serological biomarkers for detection of non-alcoholic fatty
liver disease (NAFLD) and/or advanced liver fibrosis in people living with HIV.
HIV Med. 2021 Feb 2. doi: 10.1111/hiv.13060.
Int J Dermatol
- ABADIAS-GRANADO I, Navarro-Bielsa A, Ferrando-Lamana L, Requena-Calleja MA, et al
Hyperpigmentation as a guiding sign for the diagnosis of visceral leishmaniasis
in a patient with human immunodeficiency virus (HIV).
Int J Dermatol. 2021 Feb 1. doi: 10.1111/ijd.15429.
J Acquir Immune Defic Syndr
- PAGKAS-BATHER J, Khosropour CM, Golden MR, Thibault C, et al
Population-level Effectiveness of HIV pre-exposure prophylaxis among MSM and
Transgender Persons with Bacterial Sexually Transmitted Infections.
J Acquir Immune Defic Syndr. 2021 Feb 2. pii: 00126334-900000000-95949.
- SHARMA A, Hoover DR, Shi Q, Gustafson DR, et al
High Frequency of Recurrent Falls among Pre-frail and Frail Women with and
without HIV.
J Acquir Immune Defic Syndr. 2021 Feb 2. pii: 00126334-900000000-95950.
- SABERI P, Ming K, Hojilla JC, Scott HM, et al
HIV pre-exposure prophylaxis in the time of COVID-19: How a robust and responsive
HIV PrEP intervention can avert loss of HIV prevention coverage during a global
pandemic.
J Acquir Immune Defic Syndr. 2021 Jan 29. pii: 00126334-900000000-95952.
- WAIRIMU F, Ward NC, Liu Y, Dwivedi G, et al
Cardiac transplantation in HIV positive patients: a narrative review.
J Acquir Immune Defic Syndr. 2021 Jan 29. pii: 00126334-900000000-95951.
J Clin Invest
- MATSUDA K, Migueles SA, Huang J, Bolkhovitinov L, et al
A replication competent adenovirus-vectored influenza vaccine induces durable
systemic and mucosal immunity.
J Clin Invest. 2021 Feb 2. pii: 140794. doi: 10.1172/JCI140794.
J Infect Dis
- PARK SY, Faraci G, Murphy G, Pilcher C, et al
Microdrop HIV sequencing for incidence and drug resistance surveillance.
J Infect Dis. 2021 Jan 31. pii: 6124747. doi: 10.1093.
J Virol
- ARACHCHIGE SP, Henke W, Kalamvoki M, Stephens EB, et al
Structural Domains of the Herpes Simplex Type 1 gD Protein that Restrict HIV-1
Particle Infectivity.
J Virol. 2021 Feb 3. pii: JVI.02355-20. doi: 10.1128/JVI.02355.
- GRAMATICA A, Schwarzer R, Brantley W, Varco-Merth B, et al
Evaluating a New Class of AKT/mTOR Activators for HIV Latency Reversing Activity
Ex Vivo and In Vivo.
J Virol. 2021 Feb 3. pii: JVI.02393-20. doi: 10.1128/JVI.02393.
- PILKINTON MA, McDonnell WJ, Barnett L, Chopra A, et al
In chronic infection, HIV gag-specific CD4+ T cell receptor diversity is higher
than CD8+ T cell receptor diversity and is associated with less HIV quasispecies
diversity.
J Virol. 2021 Feb 3. pii: JVI.02380-20. doi: 10.1128/JVI.02380.
Pediatr Infect Dis J
- TSONDAI PR, Davies MA, Singtoroj T, Maxwell N, et al
Improving Methods to Classify Perinatal versus Nonperinatal HIV Acquisition in
Young Adolescents 10-14 Years of Age.
Pediatr Infect Dis J. 2021 Feb 1. pii: 00006454-900000000-95880.
Pediatrics
- KONERU A, Fenlon N, Schillie S, Williams C, et al
National Perinatal Hepatitis B Prevention Program: 2009-2017.
Pediatrics. 2021 Feb 2. pii: peds.2020-1823. doi: 10.1542/peds.2020-1823.
PLoS Comput Biol
- DEARLOVE B, Tovanabutra S, Owen CL, Lewitus E, et al
Factors influencing estimates of HIV-1 infection timing using BEAST.
PLoS Comput Biol. 2021;17:e1008537.
PLoS Med
- POLITCH JA, Cu-Uvin S, Moench TR, Tashima KT, et al
Safety, acceptability, and pharmacokinetics of a monoclonal antibody-based
vaginal multipurpose prevention film (MB66): A Phase I randomized trial.
PLoS Med. 2021;18:e1003495.
PLoS One
- DE MENDONCA EB, Schmaltz CA, Sant'Anna FM, Vizzoni AG, et al
Anemia in tuberculosis cases: A biomarker of severity?
PLoS One. 2021;16:e0245458.
- PARKER B, Ward T, Hayward O, Jacob I, et al
Cost-effectiveness of the long-acting regimen cabotegravir plus rilpivirine for
the treatment of HIV-1 and its potential impact on adherence and viral
transmission: A modelling study.
PLoS One. 2021;16:e0245955.
- KHAN MS, Rego S, Rajal JB, Bond V, et al
Mitigating the impact of COVID-19 on tuberculosis and HIV services: A
cross-sectional survey of 669 health professionals in 64 low and middle-income
countries.
PLoS One. 2021;16:e0244936.
- ROOZEN GVT, Meel R, Peper J, Venter WDF, et al
Electrocardiographic and echocardiographic abnormalities in urban African people
living with HIV in South Africa.
PLoS One. 2021;16:e0244742.
- ADEDINI SA, Mobolaji JW, Alabi M, Fatusi AO, et al
Changes in contraceptive and sexual behaviours among unmarried young people in
Nigeria: Evidence from nationally representative surveys.
PLoS One. 2021;16:e0246309.
- GBEASOR-KOMLANVI FA, Zida-Compaore WIC, Sadio AJ, Tchankoni MK, et al
HIV testing uptake and prevalence among hospitalized older adults in Togo: A
cross-sectional study.
PLoS One. 2021;16:e0246151.
- HIDALGO-TENORIO C, Garcia-Martinez CM, Pasquau J, Omar-Mohamed-Balgahata M, et al
Risk factors for >/=high-grade anal intraepithelial lesions in MSM living with
HIV and the response to topical and surgical treatments.
PLoS One. 2021;16:e0245870.
- AYERDI AGUIRREBENGOA O, Vera Garcia M, Arias Ramirez D, Gil Garcia N, et al
Low use of condom and high STI incidence among men who have sex with men in PrEP
programs.
PLoS One. 2021;16:e0245925.
- LIM RK, Semitala FC, Atuhumuza E, Sabiti L, et al
Patient choice improves self-efficacy and intention to complete tuberculosis
preventive therapy in a routine HIV program setting in Uganda.
PLoS One. 2021;16:e0246113.
- CARTER G, Woodward B, Ohmit A, Gleissner A, et al
Primary care providers as a critical access point to HIV information and services
for African American and Latinx communities.
PLoS One. 2021;16:e0246016.
- FISEHA T, Ahmed E, Chalie S, Gebreweld A, et al
Prevalence and associated factors of impaired renal function and albuminuria
among adult patients admitted to a hospital in Northeast Ethiopia.
PLoS One. 2021;16:e0246509.
- TYRBERG E, Eden A, Eriksen J, Nilsson S, et al
Higher plasma drug levels in elderly people living with HIV treated with
darunavir.
PLoS One. 2021;16:e0246171.
- KIYAGA C, Narayan V, McConnell I, Elyanu P, et al
Uganda's "EID Systems Strengthening" model produces significant gains in testing,
linkage, and retention of HIV-exposed and infected infants: An impact evaluation.
PLoS One. 2021;16:e0246546.
- KUSEMERERWA S, Akena D, Nakanjako D, Kigozi J, et al
Strategies for retention of heterosexual men in HIV care in sub-Saharan Africa: A
systematic review.
PLoS One. 2021;16:e0246471.
- KIM TO, Lee JK, Kwon YS, Kim YI, et al
Clinical characteristics and prognosis of patients with Pneumocystis jirovecii
pneumonia without a compromised illness.
PLoS One. 2021;16:e0246296.
PLoS Pathog
- RENNER N, Mallery DL, Faysal KMR, Peng W, et al
A lysine ring in HIV capsid pores coordinates IP6 to drive mature capsid
assembly.
PLoS Pathog. 2021;17:e1009164.
- DINKELE R, Gessner S, McKerry A, Leonard B, et al
Capture and visualization of live Mycobacterium tuberculosis bacilli from
tuberculosis patient bioaerosols.
PLoS Pathog. 2021;17:e1009262.
Vaccine
- SEREMBA E, Ocama P, Ssekitoleko R, Mayanja-Kizza H, et al
Immune response to the hepatitis B vaccine among HIV-infected adults in Uganda.
Vaccine. 2021 Jan 27. pii: S0264-410X(21)00070.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016